# | Title | Journal | Year | Citations |
---|
1 | Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments | Brain Pathology | 2009 | 2,884 |
2 | Toll-like receptor 2 controls expansion and function of regulatory T cells | Journal of Clinical Investigation | 2006 | 658 |
3 | TRPM7, a novel regulator of actomyosin contractility and cell adhesion | EMBO Journal | 2006 | 323 |
4 | LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis | Neuron | 2012 | 312 |
5 | Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients | Cancer Research | 2013 | 295 |
6 | Programmed Death Ligand 2 in Cancer-Induced Immune Suppression | Clinical and Developmental Immunology | 2012 | 282 |
7 | Radical changes in multiple sclerosis pathogenesis | Biochimica Et Biophysica Acta - Molecular Basis of Disease | 2011 | 269 |
8 | Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody | Blood | 2005 | 265 |
9 | 19F MRI for quantitative in vivo cell tracking | Trends in Biotechnology | 2010 | 252 |
10 | Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice | Bone Marrow Transplantation | 2014 | 252 |
11 | Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity | British Journal of Cancer | 2006 | 248 |
12 | Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro | Journal of Controlled Release | 2010 | 242 |
13 | Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production | Blood | 2008 | 230 |
14 | Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy | Cancer Immunology, Immunotherapy | 2010 | 220 |
15 | The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells | Blood | 2012 | 217 |
16 | Dendritic Cell Interaction with Candida albicans Critically Depends on N-Linked Mannan | Journal of Biological Chemistry | 2008 | 209 |
17 | Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics | Lab on A Chip | 2013 | 204 |
18 | CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responsesin vivo | International Journal of Cancer | 2007 | 199 |
19 | Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process | PLoS ONE | 2011 | 199 |
20 | Myosin II and mechanotransduction: a balancing act | Trends in Cell Biology | 2007 | 193 |
21 | Molecular Repolarisation of Tumour-Associated Macrophages | Molecules | 2019 | 191 |
22 | Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients | Clinical Cancer Research | 2009 | 172 |
23 | The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells | Biomaterials | 2011 | 167 |
24 | Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity | Blood | 2011 | 155 |
25 | Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets | Blood | 2013 | 154 |
26 | Targeting Aberrant Sialylation in Cancer Cells Using a Fluorinated Sialic Acid Analog Impairs Adhesion, Migration, and In Vivo Tumor Growth | Molecular Cancer Therapeutics | 2013 | 154 |
27 | HDAC inhibitors and immunotherapy; a double edged sword? | Oncotarget | 2014 | 145 |
28 | In vivo cytometry of antigen‐specific t cells using 19F MRI | Magnetic Resonance in Medicine | 2009 | 142 |
29 | Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration | Cancer Immunology, Immunotherapy | 2008 | 141 |
30 | A Critical Role for Prostaglandin E2 in Podosome Dissolution and Induction of High-Speed Migration during Dendritic Cell Maturation | Journal of Immunology | 2006 | 133 |
31 | TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas | Journal of Immunology | 2008 | 127 |
32 | TRPM7 Regulates Myosin IIA Filament Stability and Protein Localization by Heavy Chain Phosphorylation | Journal of Molecular Biology | 2008 | 125 |
33 | Functional Differences Between Mesenchymal Stem Cell Populations Are Reflected by Their Transcriptome | Stem Cells and Development | 2010 | 124 |
34 | Probing the compressibility of tumor cell nuclei by combined atomic force–confocal microscopy | Physical Biology | 2013 | 120 |
35 | Organization of the Integrin LFA-1 in Nanoclusters Regulates Its Activity | Molecular Biology of the Cell | 2006 | 118 |
36 | Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines | Seminars in Immunology | 2011 | 118 |
37 | Interplay between myosin IIA-mediated contractility and actin network integrity orchestrates podosome composition and oscillations | Nature Communications | 2013 | 117 |
38 | Targeting antigens to dendritic cells in vivo | Immunobiology | 2006 | 112 |
39 | Targeting Nanoparticles to Dendritic Cells for Immunotherapy | Methods in Enzymology | 2012 | 110 |
40 | Targeting dendritic cells—why bother? | Blood | 2013 | 106 |
41 | Ligand-Conjugated Quantum Dots Monitor Antigen Uptake and Processing by Dendritic Cells | Nano Letters | 2007 | 105 |
42 | Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation | Blood | 2011 | 104 |
43 | Dual-color superresolution microscopy reveals nanoscale organization of mechanosensory podosomes | Molecular Biology of the Cell | 2013 | 104 |
44 | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity | Nature Communications | 2021 | 99 |
45 | Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion | Journal of Immunology | 2013 | 98 |
46 | Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation | Nature Communications | 2016 | 95 |
47 | Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network | Frontiers in Immunology | 2013 | 93 |
48 | Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake | Journal of Experimental Medicine | 2006 | 92 |
49 | Dendritic cell vaccination and immune monitoring | Cancer Immunology, Immunotherapy | 2008 | 91 |
50 | Synaptic PI(3,4,5)P3 Is Required for Syntaxin1A Clustering and Neurotransmitter Release | Neuron | 2013 | 91 |